AWP vs JRI

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score and extremely weak technical trend (10/100) raise concerns. Despite a high dividend yield of 12.24%, the unsustainable payout ratio of 685.71% and negative earnings growth (-67.70% YoY) undermine long-term viability. Valuation metrics are stretched, with a P/E of 55.57 versus a sector average of 20.94, while revenue growth, though strong at 46.10%, is not translating into earnings or cash flow. The stock trades significantly above the Graham Number of $2.44, suggesting overvaluation relative to defensive investing standards.

The deterministic health profile for JRI is critically weak, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental deterioration. While the fund offers an attractive dividend yield of 12.51%, the 90% payout ratio suggests limited sustainability and potential capital erosion. The current price of $12.81 trades at a premium to the growth-based intrinsic value of $12.32, and the technical trend is completely bearish (0/100). Overall, the combination of poor financial health scores and negative price momentum outweighs the high yield.